Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.90% sank 0.15% to $71.77 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.01% rising 0.08% to 4,662.85 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.03% falling 0.56% to 35,911.81. This was the stock's third consecutive day of losses. Gilead Sciences Inc. closed $2.35 below its 52-week high ($74.12), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.75% fell 0.55% to $167.84, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.59% rose 0.07% to $81.38, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.47% rose 1.76% to $135.87. Trading volume (8.3 M) eclipsed its 50-day average volume of 7.2 M.